Hunan Fangsheng Pharmaceutical Co., Ltd.

SSE:603998.SS

10.78 (CNY) • At close June 10, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011
Revenue 1,777.4941,628.5421,792.0011,566.9731,278.7651,093.7541,051.077720.769534.257468.559415.613400.262332.305262.675
Cost of Revenue 500.368519.538586.285563.272463.709299.565272.919288.499271.087206.078217.551234.522183.668153.273
Gross Profit 1,277.1261,109.0041,205.7161,003.701815.056794.189778.158432.27263.17262.481198.062165.739148.638109.402
Gross Profit Ratio 0.7180.6810.6730.6410.6370.7260.740.60.4930.560.4770.4140.4470.416
Reseach & Development Expenses 139.214107.92670.39651.453.61641.23342.34820.94412.85415.6612.27710.63411.7259.709
General & Administrative Expenses 32.203146.41141.03329.25431.84221.11115.76218.3717.92318.13913.0369.2419.7856.447
Selling & Marketing Expenses 600.378657.685755.249633.488484.19541.813534.264223.11279.11369.40937.27927.07726.42714.109
SG&A 632.581805.792796.282662.741516.032562.924550.026241.48297.03687.54850.31536.31936.21220.556
Other Expenses 219.987-0.376128.572146.071123.15188.5640.1040.1564.8996.4926.0893.8582.7192.777
Operating Expenses 991.782912.558995.25860.213692.798692.721669.257339.03181.048160.399103.51480.09273.42850.707
Operating Income 285.344196.446332.03999.694103.23896.36192.08380.20783.989108.88795.00184.97875.75459.371
Operating Income Ratio 0.1610.1210.1850.0640.0810.0880.0880.1110.1570.2320.2290.2120.2280.226
Total Other Income Expenses Net 0.6436.893-5.465-8.903-34.266-1.8850.1040.1564.4385.8245.8543.8442.5912.763
Income Before Tax 285.988203.338326.57590.79168.97294.47592.18780.36388.623114.71100.85588.82278.34562.133
Income Before Tax Ratio 0.1610.1250.1820.0580.0540.0860.0880.1110.1660.2450.2430.2220.2360.237
Income Tax Expense 36.13923.71449.87320.8715.19515.50112.3815.73915.18817.79914.98113.20511.32510.528
Net Income 255.216186.823285.85370.04163.79478.91172.99459.6869.75690.67680.99373.43566.11451.876
Net Income Ratio 0.1440.1150.160.0450.050.0720.0690.0830.1310.1940.1950.1830.1990.197
EPS 0.590.430.670.160.150.190.170.140.160.210.320.230.210.16
EPS Diluted 0.580.420.670.160.150.180.170.140.160.210.320.230.210.16
EBITDA 384.026310.089444.313187.541156.254170.687141.756122.143121.1121.893111.48799.26589.8473.079
EBITDA Ratio 0.2160.190.2480.120.1220.1560.1350.1690.2270.260.2680.2480.270.278